Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of “Buy” by Brokerages

Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received an average recommendation of “Buy” from the eight analysts that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price […]

Leave a Reply

Your email address will not be published.

Previous post Cogeco Communications Inc. (TSE:CCA) Receives C$76.10 Average PT from Brokerages
Next post AAON (AAON) Expected to Announce Quarterly Earnings on Thursday